Cited by 364Bipolar Disorder and TreatmentGenetic Associations and EpidemiologySchizophrenia research and treatment

Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia

Open access
Ruderfer, D M, Fanous, A H, Ripke, S, McQuillin, A, Amdur, R L, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Cross-Disorder Working Group of the Psychiatric Genomics Consortium +18 more·2014·Molecular Psychiatry

Abstract

Bipolar disorder and schizophrenia are two often severe disorders with high heritabilities. Recent studies have demonstrated a large overlap of genetic risk loci between these disorders but diagnostic and molecular distinctions still remain. Here, we perform a combined genome-wide association study (GWAS) of 19 779 bipolar disorder (BP) and schizophrenia (SCZ) cases versus 19 423 controls, in addition to a direct comparison GWAS of 7129 SCZ cases versus 9252 BP cases. In our case-control analysis, we identify five previously identified regions reaching genome-wide significance (CACNA1C, IFI44L, MHC, TRANK1 and MAD1L1) and a novel locus near PIK3C2A. We create a polygenic risk score that is significantly different between BP and SCZ and show a significant correlation between a BP polygenic risk score and the clinical dimension of mania in SCZ patients. Our results indicate that first, combining diseases with similar genetic risk profiles improves power to detect shared risk loci and second, that future direct comparisons of BP and SCZ are likely to identify loci with significant differential effects. Identifying these loci should aid in the fundamental understanding of how these diseases differ biologically. These findings also indicate that combining clinical symptom dimensions and polygenic signatures could provide additional information that may someday be used clinically.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2013.138

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genetic correlation between SCZ and BD is remarkably high (rg = 0.67).

    “Given that genetic correlation between SCZ and BD is remarkably high (rg = 0.67)46,53,54, these findings suggest cellular substrates for molecular convergence (Ex7 and In6 are shared between two disorders) and divergence (Ex1 is BD-specific, while Ex2 is SCZ-specific) among two highly genetically correlated disorders.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [31]Spitzer R Endicott J Robins E Research Diagnostic Criteria for a selected group of functional disorders 1978 New York State Psychiatric Institute. New York 3rd edition
  2. [38]Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 Nature genetics 2011 43 10 977 83 Epub 2011/09/20 21926972 PMC3637176

Cited by

Sorted by citations

Authors
Ruderfer, D. M., Fanous, A. H., Ripke, S., McQuillin, A., Amdur, R. L., Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Cross-Disorder Working Group of the Psychiatric Genomics Consortium, Gejman, P. V., O'Donovan, M. C., Andreassen, O. A., Djurovic, S., Hultman, C. M., Kelsoe, J. R., Jamain, S., Landén, M., Leboyer, M., Nimgaonkar, V, Nurnberger, J., Smoller, J. W., Craddock, N., Corvin, A., Sullivan, P. F., Holmans, P., Sklar, P., & Kendler, K. S.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • Georgetown University (US)
  • Broad Institute (US)
  • University College London (GB)
  • Washington DC VA Medical Center (US)
  • Endeavor Health (US)
  • Oslo University Hospital (NO)
  • Karolinska Institutet (SE)
  • University of California San Diego (US)
  • Inserm (FR)
  • University of Pittsburgh (US)
  • Trinity College Dublin (IE)
  • University of North Carolina at Chapel Hill (US)
  • Virginia Commonwealth University (US)
Corresponding author
  • Sklar, P
  • Kendler, K S
Venue
Molecular Psychiatry
Published
2013-11-26
Volume
19
Issue
9
Pages
1017-1024
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W1970528899
Cited by
364
References
47
Citations by year
2026: 9 · 2025: 14 · 2024: 17 · 2023: 24 · 2022: 26 · 2021: 22 · 2020: 36 · 2019: 42 · 2018: 50 · 2017: 44 · 2016: 35 · 2015: 24 · 2014: 20
FWCI
18.66
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Worcester Research and Publications (University of Worcester) (submittedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • Purdue University Indianapolis (Indiana University) (submittedVersion)
Funders
  • National Institutes of Health (5u01mh094432-04)
  • National Institute of Mental Health (U01 MH094432, R01MH097276)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
bipolar disorder, schizophrenia, polygenic risk score, shared genetic risk loci, CACNA1C, IFI44L, major histocompatibility complex, MAD1L1, PIK3C2A, mania
MeSH terms
Bipolar Disorder, Factor Analysis, Statistical, Humans, Nuclear Proteins, Phenotype, Schizophrenia, Schizophrenic Psychology, Odds Ratio, Case-Control Studies, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Calcium Channels, L-Type, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review